|
|
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
Biomarkers of Kidney Disease, Second Edition, focuses on the basic
and clinical research of biomarkers in common kidney diseases,
detailing the characteristics of an ideal biomarker. The latest
techniques for biomarker detection, including metabolomics and
proteomics are covered in the book. This comprehensive book details
the latest advances made in the field of biomarker research and
development in kidney diseases. The book is an ideal companion for
those interested in biomarker research and development, proteomics
and metabolomics, kidney diseases, statistical analysis,
transplantation, and preeclampsia. New chapters include biomarkers
of cardiovascular disease in patients with CKD, biomarkers of
Polycystic Kidney Disease, and biomarkers and the role of
nanomedicine.
Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of
Metastasis, and Sources of Therapy Resistance introduces the basic
concepts and advanced understanding of cancer stem cells, covering
general overviews, organ-specific identifications, and their
characteristic mechanisms. The book also explores innovative
therapeutic strategies in preclinical and clinical trials to target
cancer stem cells, remove the roots of cancer, eliminate the seeds
of metastasis, overcome the resistance of therapies, and contribute
to the eradication of cancer. The book includes contributions from
leading, worldwide experts in the field, helping readers embrace
new hope in their quest to eradicate cancer with emerging clinical
trials on treating cancer stem cells in combination with other
therapies.
In this issue of Hematology/Oncology Clinics, guest editors Drs.
Kimmie Ng and Benjamin L. Schlechter bring their considerable
expertise to the topic of Colorectal Cancer. Despite tremendous
progress in the management of this disease, many questions and
controversies remain regarding screening, adjuvant therapy for
resected colon cancers, targeted therapies and immunotherapy for
patients with advanced disease, surgical management, and more. In
this issue, top experts in the field address provide clinicians
with the tools to individualize management and optimize care for
this growing patient population. Contains 13 relevant,
practice-oriented topics including screening for colorectal cancer;
hereditary colorectal cancer; disparities in colorectal cancer;
microbiome in colorectal cancer; impact of diet and exercise on
colorectal cancer; colorectal cancer in younger adults; and more.
Provides in-depth clinical reviews on colorectal cancer, offering
actionable insights for clinical practice. Presents the latest
information on this timely, focused topic under the leadership of
experienced editors in the field. Authors synthesize and distill
the latest research and practice guidelines to create clinically
significant, topic-based reviews.
Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic
and Therapeutic Interventions presents cutting edge research on the
adverse cardiac effects of both radiotherapy and chemotherapy,
brought together by leaders in the field. Cancer treatment-related
cardiotoxicity is the leading cause of treatment-associated
mortality in cancer survivors and is one of the most common
post-treatment issues among survivors of adult cancer. Early
detection of the patients prone to developing cardiotoxicity,
taking in to account the type of treatment, history and other risk
factors, is essential in the fight to decrease cardiotoxic
mortality. This illustrated reference describes the most effective
diagnostic and imaging tools to evaluate and predict the
development of cardiac dysfunction for those patients undergoing
cancer treatment. In addition, new guidelines on imaging for the
screening and monitoring of these patients are also presented.
Anticancer Treatments and Cardiotoxicity is an essential reference
for those involved in the research and treatment of cardiovascular
toxicity.
Cancer is a leading cause of death that affects numerous people at
every age and their relatives. In recent years, there has been a
tremendous advancement in imaging and biotechnology technologies
and techniques for aiding in the detection, diagnosis, and
treatment of cancer. Emerging Developments and Practices in
Oncology provides research on recent advances in oncology aiming to
improve early detection and personalized treatment of cancer. While
highlighting applied methods of therapy, such as body radiotherapy,
chemoradiotherapy, and immunotherapy, readers learn about the
transforming approach to oncology in modern medicine and new
technologies used to diagnose and treat cancer. This book is an
important resource for medical trainees, graduate students, active
practitioners, researchers, and clinical scientists seeking current
research on oncology trends and applications.
Nanobiomaterials in Cancer Therapy presents the major applications
of nanobiomaterials in oncology, offering an up-to-date overview of
the latest research in this field. Utilizing nanobiomaterials,
novel therapeutic approaches enable significant improvements in
drug-loading capacity, formulation stability and drug efficiency.
In this book, leading researchers from around the world share their
expertise and unique insights. The book covers the fabrication
methods of platforms for multimodal and combinatorial therapeutic
options, along with simultaneous and real-time cancer imaging, and
innovative approaches for oncology by passive or active pathways of
multifunctional nanocarriers. The work also classifies and
discusses engineered nanobiosystems for cancer therapy, prevention,
and low cancer recurrence or relapse. This book will be of interest
to postdoctoral researchers, professors and students engaged in the
fields of materials science, biotechnology and applied chemistry.
It will also be highly valuable to those working in industry,
including pharmaceutics and biotechnology companies, medical
researchers, biomedical engineers and advanced clinicians.
Advances in Cancer Research provides invaluable information on the
exciting and fast-moving field of cancer research, presenting
outstanding and original reviews on a variety of topics.
Autophagy: Cancer, Other Pathologies, Inflammation, Immunity,
Infection, and Aging: Volume 9: Human Diseases and Autophagosome
offers a valuable guide to both cellular processes while helping
researchers explore their potentially important connections. Volume
9 emphasizes the role of autophagy in diseases, such as leukemia,
antifungal and antibacterial immunity, and transplantation. This
volume also explains, in detail, the molecular mechanism(s)
underlying the formation of autophagosomes, including the
progression of omegasomes to autophagosomes. This information is
important because one of the major functions of autophagy is to
degrade and eliminate excessive, old, and harmful materials from
the cell. Autophagosomes receive these materials (cellular cargo)
and transport them to lysosomes for degradation. Lysosomes contain
the digestive enzymes (hydrolases) that breakdown proteins, lipids,
carbohydrates, etc. (self-digestion). To further explain this
phenomenon, the role of the endoplasmic reticulum (ER) in the
formation of autophagosomes is discussed. ULK1 and Beclin 1
proteins are also important in the initial formation of
autophagosomes, and are also discussed. Because much of the early
research in this area was carried out using yeast cells, the role
of Golgi complex in the autophagosome formation in these cells is
explained. This volume also includes an explanation of the role of
the autophagy-related gene ATG5 in cancer (e.g., gastrointestinal
cancer). Paradoxically, autophagy is a "double-edged sword" because
it eliminates some pathogens, whereas it can be used by some
intracellular pathogens to multiply and cause infection. This book
is an asset to newcomers, providing a concise overview of the role
of autophagy in necrosis and inflammation, while also serving as an
excellent reference for more experienced scientists and clinicians.
Understanding the importance and necessity of the role of autophagy
in health and disease is vital for the studies of cancer, aging,
neurodegeneration, immunology, and infectious diseases.
Comprehensive and forward-thinking, these books offer a valuable
guide to both cellular processes while inciting researchers to
explore their potentially important connections. Volume 8 Autophagy
and Human Diseases, concentrates on the role of Autophagy in human
diseases, including tumorigenesis. The diseases discussed include
melanoma, liver cancer, pancreatic cancer, and neurodegenerative
disorders. Loss of autophagy in the central nervous system causes
neurodegeneration (Alzheimers disease, Huntington's disease,
Parkin's disease, and Amyotrophic Lateral Sclerosis). Melanoma is
one of the most serious diseases in humans. Autophagy plays a key
role in the anticancer response to Chemotherapy. However, autophagy
can increase or decrease the effectiveness of chemotherapy. The
reasons for these contradictory effects are explained. Autophagy
also plays a role in idiopathic inflammatory diseases, infection,
and immunity. An explanation is given how autophagy is closely
linked to control of innate and adaptive immune responses in host
defense in part by regulating cytokine production. The role of
autophagy in cutaneous malignant melanoma is discussed in detail
and expression of Beclin 1 and LC3 autophagic genes in melanoma is
included to explain the molecular mechanisms underlying this very
serious disease, which tends to metastasize to the brain. The
effect of the treatment of this disease using Terfenadine through
the induction of autophagy and apoptosis is also included.
Autophagy and apoptosis are two main mechanisms involved in
programmed cell death. Considering that autophagy is associated
with numerous biological processes including cellular development
and differentiation, cancer (both antitumor and protumor
functions), immunity, infectious diseases, inflammation,
maintenance of homeostasis, response to cellular stress, and
degenerative diseases such as Alzheimer's, Parkinson's,
Huntington's, amyotrophic lateral sclerosis, and prion diseases,
there is a great need to understanding its role. Cell homeostasis
is achieved by balancing biosynthesis and cellular turnover. In
spite of the increasing importance of autophagy in various
pathophysiological situations (conditions) mentioned above, this
process remains underestimated and overlooked. As a consequence,
its role in the initiation, stability, maintenance, and progression
of these and other diseases (e.g., autoimmune disease) remains
poorly understood. Volumes in the Series Volume 1: Molecular
Mechanisms. Elucidates autophagy's association with numerous
biological processes, including cellular development and
differentiation, cancer, immunity, infectious diseases,
inflammation, maintenance of homeostasis, response to cellular
stress, and degenerative diseases such as Alzheimer's, Parkinson's,
Huntington's, amyotrophic lateral sclerosis, and prion diseases.
Volume 2: Role in General Diseases. Describes the various aspects
of the complex process of autophagy in a myriad of devastating
human diseases, expanding from a discussion of essential autophagic
functions into the role of autophagy in proteins, pathogens,
immunity, and general diseases. Volume 3: Role in Specific
Diseases. Explores the role of autophagy in specific diseases and
developments, including: Crohn's Disease, Gaucher Disease,
Huntington's Disease, HCV infection, osteoarthritis, and liver
injury, with a full section devoted to in-depth exploration of
autophagy in tumor development and cancer, as well as the
relationship between autophagy and apoptosis. Volume 4: Mitophagy.
Presents detailed information on the role of mitophagy, the
selective autophagy of mitochondria, in health and disease, by
delivering an in-depth treatment of the molecular mechanisms
involved in mitophagy initiation and execution, as well as the role
of mitophagy in Parkinson Disease, cardiac aging, and skeletal
muscle atrophy. Volume 5: Role in Human Diseases. Comprehensively
describes the role of autophagy in human diseases, delivering
coverage of the antitumor and protumor roles of autophagy; the
therapeutic inhibition of autophagy in cancer; and the duality of
autophagy's effects in various cardiovascular, metabolic, and
neurodegenerative disorders. Volume 6: Regulation of Autophagy and
Selective Autophagy. Provides coverage of the mechanisms of
regulation of autophagy; intracellular pathogen use of the
autophagy mechanism; the role of autophagy in host immunity; and
selective autophagy. Volume 7: Role of Autophagy in Therapeutic
Applications. Provides coverage of the latest developments in
autophagosome biogenesis and regulation; the role of autophagy in
protein quality control; the role of autophagy in apoptosis;
autophagy in the cardiovascular system; and the relationships
between autophagy and lifestyle. Volume 8: Autophagy and Human
Diseases. Reviews recent advancements in the molecular mechanisms
underlying a large number of genetic and epigenetic diseases and
abnormalities, and introduces new, more effective therapeutic
strategies, in the development of targeted drugs and programmed
cell death, providing information that will aid on preventing
detrimental inflammation. Volume 9: Human Diseases and
Autophagosome. Emphasizes the role of Autophagy in necrosis and
inflammation, explaining in detail the molecular mechanism(s)
underlying the formation of autophagosomes, including the
progression of Omegasomes to autophagosomes.
|
|